Please login to the form below

Not currently logged in
Email:
Password:

lubiprostone

This page shows the latest lubiprostone news and features for those working in and with pharma, biotech and healthcare.

Mallinckrodt pays $1.2bn for Sucampo Pharma

Mallinckrodt pays $1.2bn for Sucampo Pharma

Mallinckrodt is paying $18 per share for Sucampo and will also assume the company’s $360m debt under the terms of the deal, adding Amitizia (lubiprostone), glaucoma treatment Rescula (unoprostone isopropyl)

Latest news

  • Lilly’s Efient and Sucampo's Amitiza win NICE backing Lilly’s Efient and Sucampo's Amitiza win NICE backing

    NICE, which provides healthcare recommendations to the NHS, issued new guidance on the use of Sucampo Pharma Europe's Amitiza (lubiprostone) for adults with chronic idiopathic constipation and updated its view

  • NICE backs constipation treatment NICE backs constipation treatment

    Sucampo’s Amitiza set for NHS use in England and Wales.  . Sucampo's constipation treatment Amitiza (lubiprostone) should be available on the NHS, according to new healthcare guidance. ... For many of the patients who are refractory to standard

  • AZ drug for opioid constipation starts FDA review AZ drug for opioid constipation starts FDA review

    up to compete with Sucampo and Takeda's twice-daily Amitiza (lubiprostone).

  • An unexpected turn

    Lubiprostone. Amitiza (Takeda Pharmaceuticals). Irritable Bowel Syndrome. US. Mycophenolate mofetil (Cellcept; Roche) is an immunosupressant commonly used for treating and preventing transplant rejection.

  • IBS drug approved in the US

    The drug (lubiprostone), which was developed as part of a joint deal between Sucampo and Takeda Pharmaceuticals North America, can now be prescribed to women over the age of 18 for

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics